primary graft failure and systemic presentations of hsv infection following transplantation of an hsv-contaminated donor cornea

نویسندگان

محمدرضا جعفری‏نسب

mr jafarinasab تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم محمدعلی جوادی

ma javadi تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم فیروز میربابایی قفقازی

f mirbabaei ghafghazi تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم فرید کریمیان

f karimian تهران- پاسداران- بوستان نهم- بیمارستان لبافی نژاد- مرکز تحقیقات چشم سیدعلی میردهقان

چکیده

purposes: to report a case of primary graft failure (pgf) and systemic manifestations of herpes simplex virus (hsv) infection following transplantation of an hsv-contaminated donor cornea. patient and findings: a 28-year-old male with history of penetrating keratoplasty 12 days before, developed intraocular inflammation with marked anterior chamber reaction, graft edema and elevated intraocular pressure (iop) together with systemic manifestations such as fever and unilateral cervical adenopathy. systemic manifestations resolved after a few days but the graft edema was persistent. regraft was performed after 3 months and the previous donor tissue was evaluated by pcr for cytomegalovirus (cmv) and hsv and was positive for hsv. conclusion: hsv may be a cause of pgf, which can be transmitted by a contaminated donor cornea to the recipient. this condition may also lead to systemic symptoms.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Ocular safety and efficacy of an HSV-1 gD vaccine during primary and latent infection.

One potential complication of systemic herpes simplex virus (HSV) vaccination is that subsequent ocular infection may lead to increased immunogenic corneal scarring. Therefore, V52, a genetically engineered vaccinia virus that expresses the HSV-1 glycoprotein gD, was tested for ocular safety and for protection against ocular challenge with a stromal-disease-producing strain (McKrae) of HSV-1. T...

متن کامل

Treatment of HSV infection in late pregnancy.

Evidence-Based Answer Pregnant women with a primary or recurrent episode of genital HSV infection who are later than 36 weeks of gestation should be treated with acyclovir (Zovirax) or valacyclovir (Valtrex) for viral suppression. (Strength of Recommendation [SOR]: A, based on one systematic review.) Suppressive therapy at the time of delivery can reduce the rate of recurrence, the risk of asym...

متن کامل

Seroprevalence of HSV-1 and HSV-2 infection in the general French population.

BACKGROUND In spite of the large prevalence and growing incidence of herpes simplex infection (HSV-1 and HSV-2), relatively few large serological surveys are available worldwide and it is still difficult compare frequencies of HSV contaminations in various countries. We present the results of HERPIMAX, the first epidemiological inquiry on HSV prevalence in the general French population. METHO...

متن کامل

Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection.

To determine the relationship between antibodies to herpes simplex virus (HSV) types 1 and 2 and diagnosis of orolabial and genital herpes, a cross-sectional survey was done among 869 sexually transmitted disease clinic attendees and 1594 blood donors in London. Among clinic attenders, the prevalence of HSV-1 infection was 59.5% and that of HSV-2 infection was 22.7%, and among blood donors the ...

متن کامل

Serological Evaluation of HSV-1 and HSV-2 Infection In Pregnancy

We performed a serological evaluation of herpes simplex virus (HSV) infections at the time of labor. In order to determine the seroprevalence of asymptomatic HSV infections in pregnant women, blood samples were collected for antibody measurement from 130 randomly selected pregnant women. Presence of HSV IgG and IgM antibodies in the serum samples was tested by ELISA. The prevalence of HSV-1 gG1...

متن کامل

Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.

BACKGROUND A herpes simplex virus (HSV)-2 candidate vaccine consisting of glycoprotein D (gD2) in alum and monophosphoryl lipid A (MPL) reduced genital herpes disease in HSV-1-seronegative women but not in men or HSV-1-seropositive women. METHODS To determine the effect of HSV-1 serostatus on effectiveness of different vaccines, we tested gD2 in alum/MPL, gD2 in Freund's adjuvant, and dl5-29 ...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
بینا

جلد ۱۲، شماره ۱، صفحات ۱۰۵-۱۰۸

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023